| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Revenue | $173.0M | — |
| Cost of Revenue | $88.9M | — |
| Gross Profit | $84.1M | — |
| R&D Expense | $52.9M | — |
| SG&A Expense | $16.6M | — |
| Operating Income | -$15.8M | — |
| Pre-tax Income | -$26.4M | — |
| Income Tax | -$782K | — |
| Net Income | -$25.6M | — |
| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.2M | — |
| Accounts Receivable | $70.6M | — |
| Inventory | $12.0M | — |
| Current Assets | $109.9M | — |
| Total Assets | $147.7M | — |
| Current Liabilities | $77.3M | — |
| Long-term Debt | $2.5M | — |
| Total Liabilities |
| Line Item | 2020-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.4M | — |
| Capital Expenditures | $2.2M | — |
| Investing Cash Flow | -$2.2M | — |
| Financing Cash Flow | $38.2M | — |
| Free Cash Flow | -$22.6M | — |
| $168.1M |
| — |
| Stockholders' Equity | -$20.4M | +94.7% |